Search

everythinglearnresearchcommunity

for

Search:↓

Traditional treatment for pediatric alopecia areata is most effective and should be first choice.

Certain cancer drugs are strongly linked to nerve damage, requiring close monitoring and early treatment.

Azathioprine may help treat severe alopecia areata, but more research is needed.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

The conference reported improvements in muscle volume, skin cancer diagnosis, facial and vaginal rejuvenation, and hair growth using various laser treatments.

The document concludes that transplantology has evolved with improved techniques and materials, making transplants more successful and expanding the types of transplants possible.

The document concludes that treatments for cicatricial alopecia are not well-supported by evidence, but hair transplantation shows more predictable and satisfactory results.

Hidradenitis suppurativa is a chronic skin condition more common in women, linked to genetics and lifestyle factors, and associated with various other health issues.

Sodium hypochlorite can effectively prevent and remove Staphylococcus aureus biofilms in atopic dermatitis at high enough concentrations.

Certain skin symptoms can help detect and manage systemic lupus.

Some drugs have gained approval for new uses, while others like tricyclic antidepressants and aspirin show promise but aren't yet approved for these uses.

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

Antihelminthic drugs treat worm infections but face challenges like low treatment coverage and potential drug resistance, with various side effects reported for different drugs.

The document concludes that the skin is a complex organ providing protection, sensation, and healing, with challenges in treating conditions like itchiness.

The document concludes that early diagnosis and treatment are crucial for managing rare hair loss disorders and that more research is needed to improve treatment strategies.

No FDA-approved treatments for chemotherapy-induced hair loss existed in 2006; more research was needed.

Oral cyclosporin doesn't stop hair loss.

TNFα inhibitors are effective and well-tolerated for treating severe scalp cellulitis.

Nanotechnology could improve treatment for scars and atopic dermatitis by targeting skin issues more effectively.

Renal transplant recipients often have skin issues, especially infections, and need regular skin check-ups.

Cancer survivors need better skin care to improve their quality of life.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

Experts created guidelines to better diagnose and treat uncommon fungal skin infections.

Early recognition of skin issues in immunocompromised patients is crucial for better outcomes.

Tumor immunotherapy can cause hair loss by disrupting hair follicle immunity.

Triamcinolone acetonide is more effective than cryotherapy for hair regrowth in alopecia areata but has different side effects.

Certain drugs can cause male infertility, so fertility counseling and sperm preservation are advised.

JAK inhibitors and combination therapies show promise for treating severe alopecia areata.

Alopecia areata in Taiwan has a high disease burden and needs better research and diagnostic criteria.